STOCK TITAN

iRhythm Technologies to Participate in Two Investor Conferences in September

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
iRhythm Technologies to present at Baird 2023 Global Healthcare Conference and Morgan Stanley 21st Annual Global Healthcare Conference.
Positive
  • None.
Negative
  • None.

SAN FRANCISCO, Aug. 29, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the Company will be participating in the upcoming Baird 2023 Global Healthcare Conference and the Morgan Stanley 21st Annual Global Healthcare Conference.

iRhythm’s management is scheduled to present at Baird’s 2023 Global Healthcare Conference on Tuesday, September 12, at 9:05 am Eastern Time and at the Morgan Stanley Global Healthcare Conference on Wednesday, September 13, at 1:35 pm Eastern Time. Those interested in listening to the presentation may do so by accessing the live and archived webcast of the events, which will be available on the investors section of the Company’s website at investors.irhythmtech.com.

About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Relations Contact
Stephanie Zhadkevich
(919) 452-5430
investors@irhythmtech.com

iRhythm Media Contact:
Saige Smith
(262) 289-7065
irhythm@highwirepr.com


iRhythm Technologies, Inc.

NASDAQ:IRTC

IRTC Rankings

IRTC Latest News

IRTC Stock Data

3.07B
30.66M
1.05%
109.1%
8.24%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
San Francisco

About IRTC

irhythm is a digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining our wearable biosensing technology with cloud-based data analytics and machine- learning capabilities. our goal is to be the leading provider of first-line ambulatory electrocardiogram, or ecg, monitoring for patients at risk for arrhythmias. we have created a unique platform, zio by irhythm, which we believe allows physicians to diagnose many arrhythmias more quickly and efficiently than traditional technologies, avoiding multiple indeterminate tests, allowing for appropriate medical intervention and potentially avoiding more serious downstream medical events, including stroke.